Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Solid Biosciences Inc.

Clinical trials sponsored by Solid Biosciences Inc., explained in plain language.

Solid Biosciences Inc. SLDB NASDAQ

A gene therapy company focused on neuromuscular diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet finished but already full! 1

Gene therapy trial aims to slow duchenne muscular dystrophy in boys

Disease control Ongoing

This study tests a single dose of SGT-001 gene therapy in 12 boys (children and teens) with Duchenne muscular dystrophy. The main goal is to check safety and how well the body tolerates the treatment. Participants will be followed for about 5 years to monitor side effects and any…

Phase: PHASE1, PHASE2 • Sponsor: Solid Biosciences Inc. • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC